Patent details

Basic Information

Publication number:

EP3038616

PCT Application Number:

US2014052635

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148412760

PCT Publication Number:

WO2015031313

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS FOR TREATING BACTEREMIA AND OSTEOMYELITIS USING ORITAVANCIN

French Title of Invention:

MÉTHODES DE TRAITEMENT DE LA BACTÉRIÉMIE ET DE L'OSTÉOMYÉLITE À L'AIDE D'ORITAVANCINE

German Title of Invention:

VERFAHREN ZUR BEHANDLUNG VON BAKTERÄMIE UND OSTEOMYELITIS MIT ORITAVANCIN

SPC Number:

Dates

Filing date:

26/08/2014

Grant date:

05/04/2023

EP Publication Date:

06/07/2016

PCT Publication Date:

05/03/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

05/04/2023

EP B1 Publication Date:

05/04/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

26/08/2023

Expiration date:

26/08/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

29/03/2023

 

 

Name:

Melinta Therapeutics, Inc.

Address:

44 Whippany Road Suite 280, Morristown, NJ 07960, United States (US)

Inventor

1

Name:

MOECK, Gregory

Address:

Canada (CA)

2

Name:

ARHIN, Francis

Address:

Canada (CA)

Priority

Priority Number:

201361869823 P

Priority Date:

26/08/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/14; A61P 31/12; A61P 29/00;

Publication

European Patent Bulletin

Issue number:

202314

Publication date:

05/04/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages